HERON THERAPEUTICS INC (HRTX) Stock Analyst Earnings Estimates
NASDAQ:HRTX - Nasdaq - US4277461020 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 107.7M 24.80% | 127.044M 17.96% | 144.285M 13.57% | 161.71M 12.08% | 182.04M 12.57% | 212.06M 16.49% | 253.98M 19.77% | 288.83M 13.72% | 316.85M 9.70% | 318.55M 0.54% | 326.5M 2.50% | |
| EBITDA YoY % growth | -171.81M 20.01% | -107.716M 37.31% | -9.036M 91.61% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -174.7M 19.79% | -110.615M 36.68% | -11.528M 89.58% | 3.891M 133.75% | 17.391M 346.95% | 37.434M 115.25% | 75.004M 100.36% | 101.05M 34.73% | 121.65M 20.39% | 151.27M 24.35% | 155.24M 2.62% | |
| Operating Margin | -162.21% | -87.07% | -7.99% | 2.41% | 9.55% | 17.65% | 29.53% | 34.99% | 38.39% | 47.49% | 47.55% | |
| EPS YoY % growth | -1.73 23.11% | -0.86 50.29% | -0.09 89.53% | -0.02 73.56% | 0.07 385.77% | 0.21 209.99% | 0.36 69.35% | 0.39 10.00% | 0.44 12.99% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.01 83.00% | -0.01 66.00% | -0.01 -151.00% |
| Revenue Q2Q % growth | 38.837M 7.81% | 40.277M 22.76% | 42.917M 5.24% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -939.675K 85.42% | 239.955K 105.38% | 748.425K -82.07% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.01 150.00% | -0.01 | 0.02 | 246.99% |
| Q4 2024 Q2Q % growth | 0.02 128.57% | -0.03 | 0.05 | 173.52% |
| Q3 2024 Q2Q % growth | -0.03 82.35% | -0.03 | 0.00 | 11.76% |
| Q2 2024 Q2Q % growth | -0.06 82.86% | -0.04 | -0.02 | -47.06% |
| Q1 2024 Q2Q % growth | -0.02 92.59% | -0.09 | 0.07 | 78.21% |
| Q4 2023 Q2Q % growth | -0.07 58.82% | -0.17 | 0.10 | 58.07% |
| Q3 2023 Q2Q % growth | -0.17 55.26% | -0.30 | 0.13 | 43.02% |
| Q2 2023 Q2Q % growth | -0.35 36.36% | -0.24 | -0.11 | -47.02% |
| Q1 2023 Q2Q % growth | -0.27 57.14% | -0.21 | -0.06 | -30.40% |
| Q4 2022 Q2Q % growth | -0.17 68.52% | -0.29 | 0.12 | 41.52% |
| Q3 2022 Q2Q % growth | -0.38 25.49% | -0.38 | 0.00 | 0.92% |
| Q2 2022 Q2Q % growth | -0.55 11.29% | -0.52 | -0.03 | -6.78% |
| Q1 2022 Q2Q % growth | -0.63 -8.62% | -0.49 | -0.14 | -29.76% |
| Q4 2021 Q2Q % growth | -0.54 20.59% | -0.59 | 0.05 | 8.09% |
| Q3 2021 Q2Q % growth | -0.51 20.31% | -0.62 | 0.11 | 17.76% |
| Q2 2021 Q2Q % growth | -0.62 -1.64% | -0.57 | -0.05 | -9.72% |
| Q1 2021 Q2Q % growth | -0.58 -1.75% | -0.58 | 0.00 | 0.24% |
| Q4 2020 Q2Q % growth | -0.68 -4.62% | -0.66 | -0.02 | -2.56% |
| Q3 2020 Q2Q % growth | -0.64 -52.38% | -0.64 | 0.00 | -0.05% |
| Q2 2020 Q2Q % growth | -0.61 3.17% | -0.65 | 0.04 | 6.47% |
| Q1 2020 Q2Q % growth | -0.57 28.75% | -0.67 | 0.10 | 14.52% |
| Q4 2019 Q2Q % growth | -0.65 | -0.57 | -0.08 | -14.23% |
| Q3 2019 Q2Q % growth | -0.42 | -0.58 | 0.16 | 27.76% |
| Q2 2019 Q2Q % growth | -0.63 | -0.66 | 0.03 | 3.94% |
| Q1 2019 Q2Q % growth | -0.80 | -0.50 | -0.30 | -60.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 38.903M 12.21% | 38.165M | 738K | 1.93% |
| Q4 2024 Q2Q % growth | 40.781M 19.13% | 38.114M | 2.667M | 7.00% |
| Q3 2024 Q2Q % growth | 32.81M 4.38% | 37.672M | -4.862M | -12.91% |
| Q2 2024 Q2Q % growth | 36.024M 13.42% | 36.605M | -581K | -1.59% |
| Q1 2024 Q2Q % growth | 34.67M 17.07% | 33.635M | 1.035M | 3.08% |
| Q4 2023 Q2Q % growth | 34.233M 14.00% | 31.595M | 2.638M | 8.35% |
| Q3 2023 Q2Q % growth | 31.434M 18.35% | 33.303M | -1.869M | -5.61% |
| Q2 2023 Q2Q % growth | 31.762M 14.95% | 32.33M | -568K | -1.76% |
| Q1 2023 Q2Q % growth | 29.615M 26.24% | 30.281M | -666K | -2.20% |
| Q4 2022 Q2Q % growth | 30.03M 45.35% | 27.435M | 2.595M | 9.46% |
| Q3 2022 Q2Q % growth | 26.56M 14.33% | 27.499M | -939K | -3.41% |
| Q2 2022 Q2Q % growth | 27.63M 23.13% | 25.39M | 2.24M | 8.82% |
| Q1 2022 Q2Q % growth | 23.46M 17.18% | 23.058M | 402K | 1.74% |
| Q4 2021 Q2Q % growth | 20.66M 0.24% | 26.104M | -5.444M | -20.86% |
| Q3 2021 Q2Q % growth | 23.23M 16.32% | 26.024M | -2.794M | -10.74% |
| Q2 2021 Q2Q % growth | 22.44M -1.01% | 30.263M | -7.823M | -25.85% |
| Q1 2021 Q2Q % growth | 20.02M -21.18% | 26.243M | -6.223M | -23.71% |
| Q4 2020 Q2Q % growth | 20.61M -41.25% | 19.519M | 1.091M | 5.59% |
| Q3 2020 Q2Q % growth | 19.97M -53.14% | 17.512M | 2.458M | 14.04% |
| Q2 2020 Q2Q % growth | 22.67M -38.16% | 18.04M | 4.63M | 25.67% |
| Q1 2020 Q2Q % growth | 25.4M -19.62% | 21.657M | 3.743M | 17.28% |
| Q4 2019 Q2Q % growth | 35.08M | 32.451M | 2.629M | 8.10% |
| Q3 2019 Q2Q % growth | 42.62M | 35.246M | 7.374M | 20.92% |
| Q2 2019 Q2Q % growth | 36.66M | 32.334M | 4.326M | 13.38% |
| Q1 2019 Q2Q % growth | 31.6M | 28.599M | 3.001M | 10.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 24.98% | 24.98% | 0% | 36.38% |
| Revenue | 0% | -1.99% | 0% | 0.81% |